Newtyn Management, LLC
Source: SEC Form 13F · as of Mar 2026Newtyn Management, LLC holds 9 biotech & pharma companies tracked by BioSniper, totaling $246.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$246.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Theravance Biopharma, Inc. (TBPH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TBPHTheravance Biopharma, Inc. | 4,841,629 | $78.6M |
| QDELQuidelOrtho Corp | 4,558,472 | $74.9M |
| INDVIndivior Pharmaceuticals, Inc. | 2,000,000 | $61.0M |
| RCKTRocket Pharmaceuticals Inc. | 3,165,900 | $11.3M |
| RAREUltragenyx Pharmaceutical Inc. | 400,000 | $8.4M |
| ATAIAtai Beckley N.V. | 1,781,703 | $6.3M |
| MREOMereo BioPharma Group plc | 7,079,056 | $2.3M |
| WVEWave Life Sciences Ltd. | 300,000 | $2.2M |
| QUREuniQure N.V. | 87,684 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.